57 research outputs found

    Toll-like receptor expression in smokers with and without COPD

    Get PDF
    SummaryIntroductionChronic obstructive pulmonary disease (COPD) is characterized by non-reversible airflow limitation and systemic engagement. Bacterial colonization in the lungs is common in COPD-patients and may be associated with frequent acute exacerbations. Pattern-recognition receptors (PRRs), like Toll-like receptor 2 (TLR2), TLR4 and CD14 are expressed on most immunologic active cell types and are most likely of importance in COPD patho-physiology.Material and methodsTwenty smokers with and 20 without COPD and 20 healthy non-smokers participated in the study. At two visits, induced sputum was collected after spirometry, blood was sampled and bronchoscopy with bronchoalveolar lavage was performed. Expression of TLR2, TLR4 and CD14 on different cell types and soluble receptors were assessed in the different compartments.ResultsExpression of TLR2 was lower on sputum neutrophils and soluble TLR2 (sTLR2) was higher in the supernatant in the COPD group, indicating a down regulation of TLR2 at the transit from blood to sputum. Expression of CD14 on sputum neutrophils and gene expression of CD14 on alveolar macrophages was up-regulated in the two smoking groups compared with non-smokers. No differences between the groups were found regarding TLR4 expression.ConclusionsPattern-recognition receptors (PRRs), that are expected to make a first line of defense against invading micro-organisms, are differently regulated in smokers with COPD compared with smokers without airflow limitation and non-smokers. This is likely of importance in COPD patho-physiology, in particular for exacerbations, which often are caused by micro-organisms

    GenomgĂ„ng och strategisk utvĂ€rdering av HÄMI-serien ”Cancerframkallande Ă€mnen i tĂ€tortsluft”

    No full text
    Institutet för Miljömedicin har av NaturvĂ„rdsverket fĂ„tt i uppdrag att genomföra en strategisk utvĂ€rdering av HÄMI-serien ”Cancerframkallande Ă€mnen i tĂ€tortsluft”. För att genomföra utvĂ€rderingen har vi studerat samtliga mĂ€trapporter som publicerats inom projektet, gjort litteratursökning gĂ€llande vetenskapligt publicerade artiklar och grĂ„ litteratur, samt genomfört en semi-strukturerad intervju med samtliga utförare inom projektet. UtvĂ€rderingen har framförallt fokuserat pĂ„: lokalisering och omfattning av ingĂ„ende stĂ€der, antal och urval av individer som ska ingĂ„ i studien, kvalitetssĂ€kring av analysmetodik och jĂ€mförbarheten av analyser vid olika laboratorier, synligheten av projektet som helhet och en genomgĂ„ng av möjliga nya Ă€mnen och provtagningsmetoder som skulle kunna ingĂ„. Baserat pĂ„ detta ges ett fĂ„tal rekommendationer för seriens utveckling och revidering. VĂ„ra slutsatser kan sammanfattas som att det finns goda förutsĂ€ttningar för att synliggöra projektet bĂ€ttre genom att sammanstĂ€lla och publicera tidstrendsanalyser och populĂ€rvetenskapliga rapporter pĂ„ NV’s hemsida. Dessutom bör NV övervĂ€ga vikten av slumpartat urval av tvĂ€rsnittsbefolkningen vid rekrytering av deltagare dĂ„ deltagarfrekvensen systematiskt minskat till ca 30%, alternativt bör man införa viktningsfaktorer sĂ„ att deltagarnas svar följer den nationella proportionen av befolkningen, vilket Ă€r av sĂ€rskild vikt för rökning. Vidare bör nyttan av upprepade mĂ€tningar sĂ€ttas i förhĂ„llande till möjlighet att med dessa resurser utföra pumpad provtagning för black carbon (sot) för att fĂ„ tidsupplöst information om förbrĂ€nningspartiklar genererade av trafik, istĂ€llet för att fortsĂ€tta mĂ€ta NO2, vilket inom projektet inte visat sig vara den proxy som man önskat för trafikrelaterade luftföroreningar. Inkludering av black carbon medger att en annan viktig faktor för befolkningens hĂ€lsa kan mĂ€tas, Ă€ven om den Ă€nnu inte Ă€r klassad som cancerframkallande av IARC

    Heated Tobacco Products: Insights into Composition and Toxicity

    No full text
    Heated tobacco products (HTPs) are novel products that allow users to inhale nicotine by heating (350 °C) reconstituted tobacco rather than combustion (900 °C) as in conventional cigarettes. HTP sticks containing reconstituted tobacco come in various flavours such as menthol, citrus, etc., like electronic cigarette liquids. Thus, the composition of HTP aerosol will also vary according to the flavouring agents added. Overall, the content of toxic chemicals in HTP aerosol appears to be lower than in cigarette smoke. However, the concentrations of more than twenty harmful and potentially harmful constituents have been reported to be higher in HTP aerosol than in cigarette smoke. Further, several toxic compounds not detected in cigarette smoke are also reported in HTP aerosol. Thus, the risks of HTP use remain unknown. Most of the available data on the composition and health effects of mainstream HTP aerosol exposure are generated by the tobacco industry. Few independent studies have reported short-term pathophysiological effects of HTP use. Currently available HTP toxicity data are mainly on the pulmonary and cardiovascular systems. Moreover, there are no long-term toxicity data and, therefore, the claims of the tobacco industry regarding HTPs as a safer alternative to traditional combustible cigarettes are unsubstantiated. Furthermore, HTP aerosol contains the highly addictive substance nicotine, which is harmful to the adolescent brain, developing foetuses, pregnant women, and also adults. Hence, comprehensive studies addressing the safety profiling related to long-term HTP use are warranted. With this background, the following review summarizes the current state of knowledge on HTP toxicity on four broad lines: composition of mainstream HTP aerosol compared to traditional combustible cigarette smoke, biomarkers of HTP exposure, health effects of HTP exposure, and the harm reduction aspect

    Concentration of sST2 in serum before and after exposure in a pig barn and a LPS challenge.

    No full text
    <p>Concentration of sST2 in serum before and after exposure in a pig barn and a LPS challenge in 11 farmers and 12 healthy non-exposed control subjects. Horizontal lines indicate median values. § indicate p<0.05 for pre- and post-exposure comparisons.</p

    Concentration of sTLR2 and sCD14 in sputum and correlation between sputum sCD14 and TLR4 expression on blood neutrophils.

    No full text
    <p>Concentration of sTLR2 (A) and sCD14 (B) in sputum (controls n = 14 and farmers n = 14). P-values indicate differences between the farmers and controls. A negative correlation between sputum sCD14 and TLR4 expression on blood neutrophils (C), and a positive correlation between sCD14 and macrophages number in sputum in farmers (D).</p

    Cadmium in tobacco smokers: a neglected link to lung disease?

    No full text
    Cadmium in tobacco smoke may contribute to the development of pulmonary emphysema. However, there is poor understanding of the mechanisms behind the pathogenic role of cadmium in this and other smoking-related lung diseases. The traditional focus on the total body burden of cadmium, estimated through analysis of urine, may not fully reflect the local burden of cadmium, since it is inhaled by smokers. Thus, assessing the local accumulation of cadmium in the lungs appears more relevant, given that there is tissue-specific retention of cadmium. In this review, we outline the principal sources of cadmium exposure and the clinical effects of occupational exposure. In addition, we review evidence on local cadmium and its association with alterations in innate immunity in tobacco smokers. Moreover, we scrutinise the data on cadmium as a cause of lung disease in translational models. We conclude that cadmium may contribute to smoking-related lung diseases, possibly via an altered redox balance and by making macrophages dysfunctional. However, there is a need for new studies on local cadmium levels and their relation to pathology in long-term tobacco smokers, as well as for more in-depth studies on cellular and molecular mechanisms, to elucidate the importance of cadmium in smoking-related lung diseases

    Release of IL-6 and TNF after <i>ex vivo</i> stimulation of peripheral blood.

    No full text
    <p>Release of IL-6 and TNF after <i>ex vivo</i> stimulation of peripheral blood with TNF, LPS, Pam3Cys or pig barn dust (controls n = 13 and farmers n = 14). § indicates p<0.05 and ‡ indicates p<0.01 compared with medium control.</p
    • 

    corecore